Driving Tau Pathogenicity Seeding ‐ How Fibril Structure and Post‐Translational Modifications Alter Seeding Capacity

Alysa Kasen, Libby Breton, Lindsay Meyerdirk, Sofia Lövestam, Jacob A. McPhail, Ariel Louwrier, Sjors H. W. Scheres, Michael X. HendersonAlzheimer 2024 · DOI

TL;DR

This paper investigates how the structure and post-translational modifications (PTMs) of tau protein fibrils influence their ability to seed pathology in Alzheimer's disease (AD). The researchers found that recombinant tau fibrils mimicking the core structure of AD tau fibrils exhibit higher seeding capacity, but replicating this core structure alone isn't enough. PTMs also play a crucial role, suggesting a complex interplay between structure and modifications for tau's pathogenicity.

What Problem Does This Paper Address?

Alzheimer's disease (AD) is characterized by the accumulation of abnormal tau protein aggregates, known as neurofibrillary tangles, in neurons. These aggregates are thought to spread pathology through a "prion-like" seeding mechanism, where misfolded tau can induce other tau proteins to misfold. While it's known that tau fibrils from AD brains can seed pathology in animal models, attempts to replicate this seeding using recombinant tau fibrils have largely failed. This gap highlights a critical need to understand what specific features of AD tau fibrils drive their seeding capacity. Recent advances in structural biology have revealed that tau fibril structures vary across different tauopathies but are conserved within a single disease, suggesting structure is key to pathogenicity. The authors aim to unravel the relative contributions of tau fibril structure and post-translational modifications (PTMs) to this seeding capacity, hypothesizing that recombinant fibrils mimicking AD tau's core structure, with PTMs playing a modulatory role, will show similar seeding potential.

Methods

The researchers employed a multi-pronged approach to dissect the seeding capacity of tau fibrils. They began with an in vitro screening of a panel of recently developed recombinant tau fibrils, which were engineered to possess diverse structures. This screening allowed them to assess how different fibril structures correlated with tau seeding capacity in primary cortical neurons. Following this initial screen, promising fibril candidates were further evaluated using in vivo models. Specifically, these selected fibrils were injected into the hippocampus of wild-type mice and mice engineered with a knock-in of the human MAPT gene (MAPT KI mice) to observe their pathological seeding potential in a more complex biological system.

Datasets

Not discussed in the paper.

Key Insights and Ideas

  • Structure is a major driver, but not the whole story: The study strongly suggests that the specific structural arrangement of tau fibrils, particularly the core region, is a primary determinant of their ability to seed pathology. This aligns with previous structural findings in tauopathies.
  • PTMs are critical modulators: While replicating the core structure of AD tau fibrils boosts seeding capacity, it's not sufficient on its own. The findings indicate that the regions outside this core, which are rich in PTMs, are essential for fully recapitulating the seeding power of native AD tau fibrils.
  • PTMs enhance seeding, but don't fully compensate for structural differences: The presence of PTMs on tau fibrils generally increased their seeding capacity compared to full-length fibrils lacking these modifications. However, even with PTMs, the seeding capacity didn't reach the level of native AD tau fibrils, implying that a combination of specific structure and PTM patterns is required for maximal pathogenicity.
  • Towards better AD models: The ability to generate recombinant tau fibrils that more closely mimic AD tau structures and PTMs opens doors for developing more accurate and predictive animal models of tau pathology in AD.

Key Results

  • In vitro: Recombinant tau fibrils that more closely resembled the core structure of AD tau fibrils (AD PHFs) demonstrated higher seeding capacity in primary cortical neurons compared to other fibril structures.
  • In vivo: This observation was validated in both wild-type and MAPT KI mice, where fibrils with structures closer to AD PHFs showed enhanced seeding.
  • PTM impact: Tau fibrils engineered to contain PTMs exhibited a higher seeding capacity than full-length fibrils without PTMs.
  • Synergy required: Neither replicating the core structure alone nor the presence of PTMs alone was sufficient to fully match the seeding capacity of native AD PHFs.

Limitations and Future Work

The authors acknowledge that while their findings highlight the importance of structure and PTMs, the precise mechanisms by which these factors influence seeding capacity require further investigation. They suggest that future work should focus on generating recombinant fibrils that more accurately recapitulate the complex interplay of both structural features and PTM patterns found in native AD tau fibrils. This could lead to the development of improved in vitro and in vivo models that better reflect the disease process, ultimately aiding in the discovery of therapeutic strategies for Alzheimer's disease.

Summary updated

Abstract

Abstract Background The accumulation of hyperphosphorylated, aggregated tau in neurons is one of the hallmarks of Alzheimer’s disease (AD). Recent work in structural biology has solved the structure of tau fibrils in several tauopathies and found that the structure of the tau fibrils varies between diseases, but fibril structure is conserved among patients within the same disease, suggesting fibril structure relates to its pathogenicity. Tau fibrils derived from AD brain (AD PHFs) seed AD‐like pathology in wild‐type mice, yet efforts to recapitulate this seeding with recombinant fibrils have failed. The differential capacity of tau fibrils to seed pathology also supports the relevance of tau structure to its pathogenicity. We hypothesized that recombinant fibrils that recapitulate the core region structure of AD tau will show similar seeding capacity to AD tau, with PTMs playing a modulatory role. Methods We took advantage of recently developed recombinant tau fibrils with diverse structures to investigate how tau fibril structure and PTMS are related to tau seeding capacity in primary cortical neurons. Fibrils of interest from the screen were then assessed through hippocampal injection into wild‐type and MAPT knock‐in mice. Results In‐ vitro screening showed that fibrils more closely resembling the core structure of an AD PHF had a higher seeding capacity than other fibrils. However, the replication of the core structure alone in truncated fibrils is not sufficient to fully replicate the seeding capacity of AD PHFs, indicating that the region outside of the core structure, containing PTMs, likely plays an essential role in pathology seeding. This finding was replicated in the seeding model into wild‐type and MAPT KI mice. We also found that tau fibrils containing PTMs had a higher seeding capacity than full length fibrils without PTMs. However, the presence of PTMs alone was not enough to fully replicate the seeding capacity of AD PHFs. Conclusions The structure and PTM patterns of tau fibrils appear to be closely tied to fibril pathogenicity, with recombinant fibrils more closely resembling AD PHFs having a more similar seeding capacity. We believe that the generation of fibrils closely resembling AD PHFs can lead to improved model systems of tau pathology in AD.
BibTeX
@inproceedings{kasen2024driving,
  author = {Alysa Kasen and Libby Breton and Lindsay Meyerdirk and Sofia Lövestam and Jacob A. McPhail and Ariel Louwrier and Sjors H. W. Scheres and Michael X. Henderson},
  title = {{Driving Tau Pathogenicity Seeding ‐ How Fibril Structure and Post‐Translational Modifications Alter Seeding Capacity}},
  booktitle = {Alzheimer},
  year = {2024},
  doi = {10.1002/alz.094584},
}
Figure